Amélie Chollet | CMS – Global Relay Intelligence & Practice

Amélie Chollet | CMS

Amélie Chollet is a partner in CMS’s Life Sciences & Healthcare group, specialising in legal regulatory issues affecting life sciences companies operating in the UK and in the EU.

Amelie.Chollet@cms-cmno.com

AI

EC consults on high-risk AI systems in life sciences and healthcare

July 2, 2025

Many life sciences and healthcare companies develop or deploy AI-based medical devices and digital health solutions that may fall within the high-risk category.

Amélie Chollet | CMS, Dr. Roland Wiring3 min read

Topics

Latest News

ASIC roundup: Cairns pawnbroker fined A$12,000, and uptake in SBRs

US Treasury escalates financial offensive against fentanyl networks

CFTC says commodity pool operator mischaracterized risk-management practices

Topics

Latest News

FCA proposes once-in-a-generation changes to UK financial advice services

CFPB unveils future plans for criminally liable offenses

Asia-Pacific in focus: June 2025 at a glance

Topics

Latest News

EC consults on high-risk AI systems in life sciences and healthcare

How HR teams can play a key part in the roll out of AI

Senate Banking Committee offers up crypto market structure principles

Topics

Latest News

FCA's Rusu emphasizes AI's role in shaping future financial regulation

Two new deputy directors appointed to the Danish Financial Supervisory Authority

GRIP Extra: House of Representatives bans WhatsApp, Germany plans to ban DeepSeek

EC consults on high-risk AI systems in life sciences and healthcare